
Thomas Sweeney Heard
Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1286 |
| Issued Applications | 710 |
| Pending Applications | 90 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9839025
[patent_doc_number] => 20150031106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'HCV PROTEASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/293444
[patent_app_country] => US
[patent_app_date] => 2014-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 39150
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14293444
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/293444 | HCV PROTEASE INHIBITORS AND USES THEREOF | Jun 1, 2014 | Abandoned |
Array
(
[id] => 10769040
[patent_doc_number] => 20160115196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'SELF-ASSEMBLED MICRO-AND NANOSTRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 14/894043
[patent_app_country] => US
[patent_app_date] => 2014-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 20908
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894043
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/894043 | SELF-ASSEMBLED MICRO-AND NANOSTRUCTURES | May 27, 2014 | Abandoned |
Array
(
[id] => 10782940
[patent_doc_number] => 20160129096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'GASTRIN PEPTIDE IMMUNOGENIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/892973
[patent_app_country] => US
[patent_app_date] => 2014-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15445
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892973 | Gastrin peptide immunogenic composition | May 15, 2014 | Issued |
Array
(
[id] => 10933099
[patent_doc_number] => 20140336120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury'
[patent_app_type] => utility
[patent_app_number] => 14/273343
[patent_app_country] => US
[patent_app_date] => 2014-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2408
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14273343
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/273343 | Compositions and method for treatment of ischemic neuronal reperfusion injury | May 7, 2014 | Issued |
Array
(
[id] => 9671754
[patent_doc_number] => 20140235617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'Combinations of Hepatitis C Virus Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/263101
[patent_app_country] => US
[patent_app_date] => 2014-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6285
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14263101
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/263101 | Combinations of Hepatitis C Virus Inhibitors | Apr 27, 2014 | Abandoned |
Array
(
[id] => 11002556
[patent_doc_number] => 20160199505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'PEPTIDES AND PEPTIDE/ACTIVE COMPOUND CONJUGATES FOR RENAL TARGETING'
[patent_app_type] => utility
[patent_app_number] => 14/890059
[patent_app_country] => US
[patent_app_date] => 2014-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13491
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890059
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/890059 | Peptides and peptide/active compound conjugates for renal targeting | Apr 15, 2014 | Issued |
Array
(
[id] => 9643496
[patent_doc_number] => 20140221608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'ACID-CLEAVABLE LINKERS EXHIBITING ALTERED RATES OF ACID HYDROLYSIS'
[patent_app_type] => utility
[patent_app_number] => 14/252928
[patent_app_country] => US
[patent_app_date] => 2014-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21127
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14252928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/252928 | ACID-CLEAVABLE LINKERS EXHIBITING ALTERED RATES OF ACID HYDROLYSIS | Apr 14, 2014 | Abandoned |
Array
(
[id] => 16443645
[patent_doc_number] => 10835549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Polyplexes
[patent_app_type] => utility
[patent_app_number] => 14/784017
[patent_app_country] => US
[patent_app_date] => 2014-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 79
[patent_no_of_words] => 21134
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14784017
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/784017 | Polyplexes | Apr 10, 2014 | Issued |
Array
(
[id] => 9620897
[patent_doc_number] => 08791071
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-07-29
[patent_title] => 'Cartilage material'
[patent_app_type] => utility
[patent_app_number] => 14/246588
[patent_app_country] => US
[patent_app_date] => 2014-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4095
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14246588
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/246588 | Cartilage material | Apr 6, 2014 | Issued |
Array
(
[id] => 12305868
[patent_doc_number] => 09938322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => b-hairpin peptidomimetics
[patent_app_type] => utility
[patent_app_number] => 14/781247
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18509
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781247 | b-hairpin peptidomimetics | Mar 27, 2014 | Issued |
Array
(
[id] => 10714151
[patent_doc_number] => 20160060298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'BETA-HAIRPIN PEPTIDOMIMETICS'
[patent_app_type] => utility
[patent_app_number] => 14/781229
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17209
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781229
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781229 | Beta-hairpin peptidomimetics | Mar 27, 2014 | Issued |
Array
(
[id] => 10997432
[patent_doc_number] => 20160194378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/778151
[patent_app_country] => US
[patent_app_date] => 2014-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5451
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14778151
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/778151 | PEPTIDES AND USES THEREOF | Mar 17, 2014 | Abandoned |
Array
(
[id] => 10737298
[patent_doc_number] => 20160083448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'SITE 2 INSULIN ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 14/774109
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11614
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774109
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774109 | SITE 2 INSULIN ANALOGUES | Mar 16, 2014 | Abandoned |
Array
(
[id] => 10499557
[patent_doc_number] => 09227952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Sovaprevir polymorphs and methods of manufacture thereof'
[patent_app_type] => utility
[patent_app_number] => 14/211948
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4870
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14211948
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/211948 | Sovaprevir polymorphs and methods of manufacture thereof | Mar 13, 2014 | Issued |
Array
(
[id] => 9739760
[patent_doc_number] => 20140275480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'NOVEL PROCESSES FOR PRODUCING SOVAPREVIR'
[patent_app_type] => utility
[patent_app_number] => 14/211510
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3267
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14211510
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/211510 | Processes for Producing sovaprevir | Mar 13, 2014 | Issued |
Array
(
[id] => 9739379
[patent_doc_number] => 20140275099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'METHODS FOR TREATING HCV'
[patent_app_type] => utility
[patent_app_number] => 14/210870
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10544
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/210870 | METHODS FOR TREATING HCV | Mar 13, 2014 | Abandoned |
Array
(
[id] => 9739154
[patent_doc_number] => 20140274873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'COMPOSITION OF A SUSTAINED-RELEASE DELIVERY AND METHOD OF STABILIZING PROTEINS DURING FABRICATION PROCESS'
[patent_app_type] => utility
[patent_app_number] => 14/209683
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9958
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209683
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/209683 | COMPOSITION OF A SUSTAINED-RELEASE DELIVERY AND METHOD OF STABILIZING PROTEINS DURING FABRICATION PROCESS | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10143320
[patent_doc_number] => 09176127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Method for selecting a candidate drug compound'
[patent_app_type] => utility
[patent_app_number] => 14/201523
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 24673
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14201523
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/201523 | Method for selecting a candidate drug compound | Mar 6, 2014 | Issued |
Array
(
[id] => 9772815
[patent_doc_number] => 20140296478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/201593
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 24660
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14201593
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/201593 | METHOD FOR SELECTING A CANDIDATE DRUG COMPOUND | Mar 6, 2014 | Abandoned |
Array
(
[id] => 9932103
[patent_doc_number] => 20150080295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'GLUCAGON ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 14/195533
[patent_app_country] => US
[patent_app_date] => 2014-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12048
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14195533
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/195533 | GLUCAGON ANALOGUES | Mar 2, 2014 | Abandoned |